Omnicell, Inc. (OMCL) Earnings Call Analysis

NASDAQ · Healthcare · Health Information Services

19/25

Growth 5 Margin 3 Expansion 5 Platform 2 Financial 4

latest quarter score

Earnings Reports

19
Omnicell (OMCL) Q2 2026: Pipeline Expands to Record Levels as Titan XT Drives Broader Enterprise Engagement
July 30, 2026
17
OmniCell (OMCL) Q4 2025: ARR Climbs 10% as TitanXT Launch Primes $2.5B Replacement Cycle
June 15, 2026
20
Omnicell (OMCL) Q1 2026: Gross Margin Jumps 400bps as Titan XT Pipeline Expands
April 28, 2026
17
Omnicell (OMCL) Q3 2025: Product Revenue Jumps 12%, Platform Shift Targets $10B Market Refresh
October 30, 2025
25
Omnicell (OMCL) Q2 2025: Recurring Revenue Mix Hits 50%, Driving Margin and Visibility Gains
July 31, 2025
20
Omnicell (OMCL) Q1 2025: Tariffs Slash $40M From EBITDA Guidance, Forcing Supply Chain Overhaul
July 07, 2025

Browse all companies